ZYBANK(01216): Li Wenqiang's appointment as a non-executive director has been approved.
China Resources Bank (01216) announced that it recently obtained the approval from the Henan Regulatory Bureau of the China Banking and Insurance Regulatory Commission for the appointment of Li Wenqiang as a non-executive director of the bank (Yujin Fu [2025] No. 312). According to the approval document, Mr. Li Wenqiang's appointment as a non-executive director of the bank has been approved, and his term will be from the date of this announcement until the third board of directors of the bank is re-elected. After the expiration of his term, he is eligible for reelection.
ZYBANK (01216) announced that the Bank has recently obtained the approval from the Henan Regulatory Bureau of the China Banking and Insurance Regulatory Commission regarding the qualification of Mr. Li Wenqiang as a non-executive director of ZYBANK Limited (Approval No. Yu Jin Fu [2025] 312). According to the approval document, Mr. Li Wenqiang's appointment as a non-executive director of the Bank has been approved, with his term of office starting from the date of this announcement until the third session of the Board of Directors of the Bank is reconstituted. After the expiration of his term, he is eligible for re-election.
Related Articles

BUD APAC (01876) awards 29.38 million restricted share units.

ANHUI EXPRESSWAY (00995) plans to increase its investment in the traffic control information industry by 95 million RMB, increasing its shareholding ratio to 36.76%.

Medprin Regenerative Medical Technologies (301033.SZ) Shareholders Shenzhen Kaiying and Fengyan Fund plan to reduce their holdings by no more than 1.22%.
BUD APAC (01876) awards 29.38 million restricted share units.

ANHUI EXPRESSWAY (00995) plans to increase its investment in the traffic control information industry by 95 million RMB, increasing its shareholding ratio to 36.76%.

Medprin Regenerative Medical Technologies (301033.SZ) Shareholders Shenzhen Kaiying and Fengyan Fund plan to reduce their holdings by no more than 1.22%.

RECOMMEND

Valued At $10 Trillion, The Largest IPO In History Is Coming As SpaceX Announces Listing Plan
12/12/2025

Five Imperatives And Eight Tasks: Central Meeting Specifies Next Year’s Economic Work, Highlights Identified
12/12/2025

Over 100 New Listings In Hong Kong This Year As Total Fundraising Tops HKD 270 Billion, Eighteen “A+H” Dual Listings
12/12/2025


